Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France
Feasibility Study on Estimating the Prevalence and Management of Stage 4 Chronic Kidney Disease in Adults Via Laboratories and Nephrologists in the Gard, France
Centre Hospitalier Universitaire de Nīmes
3,375 participants
Jan 1, 2019
OBSERVATIONAL
Conditions
Summary
The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.
Eligibility
Inclusion Criteria1
- chronic kidney disease (stage \>= 4)
Exclusion Criteria1
- \-
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02938611